PDA Southern California Chapter: Program on Particulates
Registration Options
Individual Registration
Group Registration
On behalf of PDA Southern California, we are delighted to invite you to join the 2024 Program on Particulates. The Particulates Meeting aims to provide a summary of the most recent information on the risks to human health associated with particulate matter. This event will take place at BioScience LA. Doors open @ 3:00 pm. Presentations begin at 4:00 pm – 8:00 pm. We look forward to having you!
Event Location
4130 Overland Ave., Culver City, CA 90230 Get DirectionsContact
Chapter Inquiries
Membership Services
Standard Registration
Member Price
$75.00Non-Member
$100.00
Day 1
Topic 1 | Annex 1, Compliant Contamination Control Strategies, Sladjan Maksimovic, Business Development Manager, Schott Pharma
Topic 2 | A Study in Improving Sustainability, while Reducing Manufacturing Costs, Robert Meisenhelter, Business Development Manager, Schott Pharma
Topic 3 | Understanding Particles and Patient Safety, Robin Manouchehri, Process Development Scientist, Amgen Inc.
Topic 4 | Particulate Challenges in Autologous Cell Therapy, Shawn (Xueyuan) Wang, Associate Director, Process Development, Kite Pharma
Topic 5 | Achieving Particle Reducation via Supplier Annex 1 Strategies and Innovation in RTF Packaging, Colleen O'Brien, Strategic Business Development Manager, Gerresheimer
Topic 6 | Enforcement Actions in Relation to Particles, Austin Caudle, Senior Account Executive, Redica Systems
Featured Presenters
-
Austin G. Caudle, MSc
Senior Account Executive, Redica
Read Bio
Austin G. Caudle, MSc
Redica
Mr. Caudle has business experience across pharmaceuticals, biotech, and medical devices helping clients to proactively interpret regulations, understand processes and product technologies, make sound decisions, facilitate change, and drive business benefit. He assists Emerging BioPharma companies plan and implement highly targeted, data-driven clinical trials to advance an asset from first-in-man through global Phase III studies. Mr. Caudle currently serves as President of the Board of Directors for the Parenteral Drug Association in the Southeast U.S. and on several conference planning committees. He holds an MS in Food Science and a BS in Nutrition Science from Auburn University.
-
Sladjan Maksimovic
Business Development Manager, SCHOTT Pharma
-
Robin Manouchehri
Process Development Scientist, Amgen
-
Robert Meisenhelter
Business Development Manager, SCHOTT Pharma
-
Colleen O'Brien
Strategic Business Development Manager, Gerresheimer
-
Shawn Wang
Associate Director Process Development, Kite Pharma
Thank You to Our Sponsors
PLEASE READ PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.